Add a Comment By Jennifer Bassett, MA, Senior Managing Editor & Content Strategist | Friday, April 11, 2014 IBM’s Watson won Jeopardy! , but what if its power could be use for the greater good to help make better cancer care choices? read more
Add a Comment By Celia Gittelson, BA | Monday, December 16, 2013 Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors. read more
Add a Comment By Christina Pernambuco-Holsten, MA | Friday, December 6, 2013 Memorial Sloan-Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines. read more
Add a Comment By Julie Grisham, MS, Science Writer/Editor | Friday, June 28, 2013 Christina Leslie develops computational and statistical methods to study gene expression in normal cells and in cancer cells. read more
Add a Comment By Celia Gittelson | Friday, June 21, 2013 Memorial Sloan-Kettering marked National Cancer Survivors Day at its Manhattan campus and at its regional sites in Westchester, New Jersey, and Long Island. read more
Add a Comment By Jim Stallard, MA, Writer/Editor | Friday, April 26, 2013 Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers , and also conducts innovative research on poxviruses. read more
Add a Comment By Jim Stallard, MA and Julie Grisham, MS Friday, September 21, 2012 With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.